Q4 2025 Clover Health Investments Corp Earnings Call Transcript
Key Points
- Clover Health Investments Corp (CLOV) achieved full year adjusted EBITDA profitability in 2025, demonstrating financial resilience despite industry challenges.
- The company reported a 38% year-over-year increase in Medicare Advantage membership, showcasing strong market growth.
- Clover Health Investments Corp (CLOV) maintained a well-controlled medical cost trend, excluding pharmacy, at 5% year-over-year.
- The company expects to achieve its first full year of GAAP net income and EPS profitability in 2026, driven by strong cohort economics and structural tailwinds.
- Clover Health Investments Corp (CLOV) demonstrated operating leverage with adjusted SG&A as a percentage of total revenue improving by 410 basis points year-over-year.
- The gross profit margin is expected to step down by 150 basis points year-on-year, despite improving cohort economics and a 4-star payment year.
- New member contribution loss was reported at $145 PMPM, indicating challenges in profitability for new cohorts.
- The company faced continued cost pressure in outpatient settings and seasonal Part D pressure related to IRA changes.
- Clover Health Investments Corp (CLOV) experienced a 970 basis point increase in insurance segment BER, driven by new member dilution and quality investments.
- The company highlighted potential challenges with CMS data sharing for new members switching from other MA plans, which could impact risk adjustment.
Hello and welcome to Clover Health's fourth quarter 2025 earnings call.
(Operator Instructions)
Ryan, you may begin.
Good afternoon everyone. Joining me on our call today to discuss the company's fourth quarter and full year 2025 results are Andrew Toy, Clover Health's Chief Executive Officer, and Peter Kuipers, the company's Chief Financial Officer. You can find today's press release in the accompanying supplemental slides, as well as the company's most recent investor deck in the investor events and presentation section of our website at investors.cloverhealth.com. This webcast is being recorded and a replay will be available in the investor relations section of the Clover Health website. I would also like to caution you that we may make forward-looking statements during today's call that are subject to risks and uncertainties, including expectations about future performance. Factors that may cause actual results to differ materially from expectations are detailed in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
